6505--Bumetanide Tablets

The contract involves the procurement of Bumetanide Tablets for the Department of Veterans Affairs, with a solicitation issued on October 24, 2025, and an amended deadline extended to November 20, 2025. It is structured as a multi-year requirements contract, with a base period and four one-year options, covering various dosages and bottle sizes. The government will award the contract in the aggregate to the lowest-priced, technically acceptable offeror that meets all technical and compliance requirements, including FDA cGMP standards and USP-NF specifications. Offerors must submit prices for all line items, including a 0.5% Cost Recovery Fee, with prices evaluated on an estimated quantity basis, though no specific total contract value is provided. The delivery is FOB destination to multiple VA and DoD distribution centers nationwide, with a requirement that products be shipped within 15 days of order receipt and no more than 15 days after contract expiration. The solicitation emphasizes strict packaging, labeling, and bar-coding standards aligned with GS1-128, HIBCC, and ANSI/ISO/IEC Grade C standards to ensure product traceability and integrity. Inspection and acceptance occur at the government’s destination facilities, with the government responsible for verifying conformance to quality standards and FDA regulations. The contract incorporates numerous FAR clauses covering representations, certifications, subcontracting plans, privacy, security, and prohibitions on certain technologies and entities. Offerors must submit proposals via email in Word or PDF format by the deadline, including a signed SF-1449, completed certifications, and all required documentation. The process is designed to ensure compliance, transparency, and adherence to federal procurement standards, with award based on price and technical acceptability.